Illness	Number of cases
Heart failure (I50.01)	315
Pneumonia organism unspecified - Pneumonia unspecified organism (J18.9)	145
Essential primary hypertension (I10.01)	143
Left ventricular failure unspecified (I50.14)	131
Volume depletion (E86)	120
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	112
Syncope and collapse (R55)	97
Atrial fibrillation and flutter (I48.1)	74
Viral pneumonia not elsewhere classified (J12.8)	72
Diarrhoea and gastroenteritis of presumed infectious origin (A09.9)	63

Top 10 treatments

Treatment	Number
(8-831.03)	1.785
(9-984.7)	621
Examination of the oesophagus, stomach and duodenum by endoscopy (1-632.0)	562
(9-984.8)	496
Taking a tissue sample (biopsy) of the upper digestive tract, biliary tract or the pancreas by endoscopy (1-440.a)	301
Computed tomography (CT) of the head without contrast medium (3-200)	301
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	274
Treatment procedure to maintain and encourage practical everyday and social skills - psychosocial intervention (9-401.22)	274
(9-984.9)	273
Computed tomography of the abdomen with contrast medium (3-225)	261

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0100

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	0
Bezeichnung
Teilnahme externe Qualitätssicherung	2
Bezeichnung
Teilnahme externe Qualitätssicherung	0

External quality assurance according to the DMP

Diabetes mellitus Typ 2

Engmaschige Kooperation mit niedergelassenen Ärzten, die am DMP teilnehmen.

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
35	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
32	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
3	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility